{
    "title": "TIMELINE-Biogen CEO to leave as Alzheimer's drug struggles",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10779195/TIMELINE-Biogen-CEO-leave-Alzheimers-drug-struggles.html",
    "date": "2022-05-03",
    "keywords": [
        "biogen",
        "drug",
        "approval",
        "aducanumab",
        "aduhelm",
        "june",
        "march",
        "disease",
        "july",
        "agency",
        "company",
        "decline",
        "regulator",
        "fda",
        "decision",
        "michel",
        "vounatsos",
        "infrastructure",
        "eisai",
        "aducanamab",
        "plaque",
        "trial",
        "market",
        "progression",
        "application",
        "staff",
        "panel",
        "reduction",
        "commission",
        "tuesday",
        "executive",
        "drugmaker",
        "university",
        "spinoff",
        "neurimmune",
        "httpsbitly3g3mlfm",
        "co",
        "ltd",
        "option",
        "httpsbitly3jgmgru",
        "sign",
        "study",
        "amyloid",
        "httpsreutrs3g1hhhm",
        "dose",
        "brain",
        "httpsreutrs37xo1gx",
        "september",
        "latestage",
        "engage",
        "emerge",
        "committee",
        "value",
        "analysis",
        "httpsreutrs3pgd8gz",
        "submission",
        "httpsbitly3e1ahlu",
        "november",
        "evidence",
        "meeting",
        "httpsreutrs3ujl4cj",
        "httpsreutrs3rd58nn",
        "health",
        "rate",
        "pathway",
        "move",
        "year",
        "person",
        "protest",
        "impairment",
        "stage",
        "probe",
        "chunk",
        "revenue",
        "buildup",
        "investigation",
        "quarter",
        "december",
        "link",
        "beta",
        "improvement",
        "price",
        "half",
        "access",
        "trade",
        "exchange",
        "partner",
        "role",
        "royalty",
        "agreement",
        "share",
        "profit",
        "journal",
        "prevention",
        "medicare",
        "medicaid",
        "coverage",
        "policy",
        "april",
        "marketing"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}